Back

Changes in antithrombotic therapy after atrial fibrillation diagnosis

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: What is the long term impact of atrial fibrillation? Insights from GARFIELD-AF Stroke Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Frank Cools

General Hospital Klina, Brasschaat (Belgium)

6 More presentations in this session

Presentation thumbnail
What have registries taught us? New insights from GARFIELD-AF
Professor A. Kakkar (London, GB)
Slides Video
Presentation thumbnail
Long-term outcomes
Professor D. Atar (Oslo, NO)
Slides Video
Presentation thumbnail
Innovations in risk assessment: an integrated risk tool for stroke, death and bleeding
Professor K. Fox (Edinburgh, GB)
Slides Video
Presentation thumbnail
Management of care in atrial fibrillation patients: impact of following guidelines for treatment of atrial fibrillation and comorbid conditions
Professor J. Camm (London, GB)
Slides Video
Presentation thumbnail
Three-way comparison of effectiveness among different classes of oral anticoagulants: GARFIELD-AF study
Professor S. Goto (Isehara, JP)
Slides Video

Access the full session

Session thumbnail
What is the long term impact of atrial fibrillation? Insights from GARFIELD-AF

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Treatment strategies for atrial fibrillation in heart failure - discussion
thumbnail
Congress Presentation
Interactive discussion and Q&A
thumbnail
Congress Presentation
Oral anticoagulation in subclinical atrial fibrillation: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources